ImmunoGen, Inc. (IMGN) Social Stream
ImmunoGen Inc (IMGN) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering ImmunoGen Inc.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
Over the past 28 weeks, IMGN's average price target has gone down $0.15.
Over the past 50 weeks, IMGN's average upside potential has been 63.3%.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
IMGN Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
IMGN's average broker recommendation rating improved by 0 over the prior 23 months.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for IMGN as an investment opportunity.
- ImmunoGen Inc's average analyst price target is greater than 65.99% of all US stocks.
- In terms of how ImmunoGen Inc fares relative to all US stocks, note that its variance in analysts' estimates is lower than -607.42% of that group.
- IMGN has a greater number of analysts covering the stock than 731.8% of stocks in the small market cap category.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, ImmunoGen Inc's upside potential (average analyst target price relative to current price) is greater than 272.63% of them.
Is IMGN a Buy, Hold or Sell? See the POWR Ratings now!